[{"Assets_0_Q2_USD":50026000.0,"CommonStockSharesOutstanding_0_Q2_shares":21483540.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15261000.0,"NetIncomeLoss_1_Q2_USD":-7312000.0,"NetIncomeLoss_2_Q2_USD":-14292000.0,"StockholdersEquity_0_Q2_USD":41336000.0,"Ticker":"VRDN","CIK":"1590750","name":"MIRAGEN THERAPEUTICS, INC.","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170811"}]